Extended Data Table 1 Deep-sequence analysis of NA protein amino acid substitutions in virus-positive brain or lung tissue
Mouse ID | Tissue | Inoculation route | Treatment regimen | PA a.a changea, b (% Frequency, read count/coverage) |
---|---|---|---|---|
76 | Brain | Ocular | OSE 200 mg/kg | No Changes |
99 | Brain | Oral | OSE 200 mg/kg | No Changes |
100 | Brain | Oral | OSE 200 mg/kg | No Changes |
109 | Brain | Oral | OSE 20 mg/kg | No Changes |
110 | Brain | Oral | OSE 20 mg/kg | No Changes |
111 | Brain | Oral | OSE 20 mg/kg | No Changes |
120 | Brain | Intranasal | OSE 200 mg/kg | No Changes |
121 | Brain | Intranasal | OSE 200 mg/kg | No Changesc |
122 | Brain | Intranasal | OSE 200 mg/kg | No Changes |
134 | Brain | Intranasal | OSE 20 mg/kg | No Changesc |
135 | Brain | Intranasal | OSE 20 mg/kg | No Changes |
136 | Brain | Intranasal | OSE 20 mg/kg | No Changes |
145 | Brain | Ocular | Non-treated | K257T (6.6%, 307/4624) |
146 | Brain | Ocular | Non-treated | No Changes |
147 | Brain | Ocular | Non-treated | No Changes |
156 | Brain | Oral | Non-treated | No Changes |
157 | Brain | Oral | Non-treated | No Changes |
158 | Brain | Oral | Non-treated | No Changes |
167 | Brain | Intranasal | Non-treated | No Changesc |
168 | Brain | Intranasal | Non-treated | No Changes |
60 | Brain | Intranasal | Non-treated | No Changes |
76 | Lung | Ocular | OSE 200 mg/kg | No Changes |
89 | Lung | Ocular | OSE 20 mg/kg | No Changes |
99 | Lung | Oral | OSE 200 mg/kg | No Changes |
100 | Lung | Oral | OSE 200 mg/kg | No Changes |
109 | Lung | Oral | OSE 20 mg/kg | No Changes |
110 | Lung | Oral | OSE 20 mg/kg | No Changes |
111 | Lung | Oral | OSE 20 mg/kg | No Changes |
120 | Lung | Intranasal | OSE 200 mg/kg | No Changes |
121 | Lung | Intranasal | OSE 200 mg/kg | No Changesc |
122 | Lung | Intranasal | OSE 200 mg/kg | No Changes |
134 | Lung | Intranasal | OSE 20 mg/kg | No Changes |
135 | Lung | Intranasal | OSE 20 mg/kg | No Changes |
136 | Lung | Intranasal | OSE 20 mg/kg | No Changes |
145 | Lung | Ocular | Non-treated | K257T (6.5%, 277/4246) |
146 | Lung | Ocular | Non-treated | D284N (12.6%, 487/3861) |
147 | Lung | Ocular | Non-treated | No Changes |
156 | Lung | Oral | Non-treated | No Changes |
157 | Lung | Oral | Non-treated | No Changes |
158 | Lung | Oral | Non-treated | No Changes |
167 | Lung | Intranasal | Non-treated | No Changesc |
168 | Lung | Intranasal | Non-treated | No Changes |
60 | Lung | Intranasal | Non-treated | No Changes |